Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

NURSEDX OF NEVADA LLC

NPI: 1114577152 · LAS VEGAS, NV 89120 · Clinical Medical Laboratory · NPI assigned 09/11/2019

$10K
Total Medicaid Paid
139,606
Total Claims
109,644
Beneficiaries
64
Codes Billed
2019-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialGAYARES, ARLENE (OWNER)
NPI Enumeration Date09/11/2019

Related Entities

Other providers sharing the same authorized official: GAYARES, ARLENE

ProviderCityStateTotal Paid
ROCKWELL HEALTHCARE, INC, LAS VEGAS NV $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 247 $0.00
2020 1,565 $0.00
2021 13,961 $0.00
2022 40,507 $148.31
2023 39,305 $2K
2024 44,021 $8K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 6,396 4,724 $2K
84443 Thyroid stimulating hormone (TSH) 9,933 7,951 $878.33
80061 Lipid panel 10,425 8,271 $876.74
80053 Comprehensive metabolic panel 13,142 10,499 $791.18
85025 Blood count; complete (CBC), automated, and automated differential WBC count 12,217 9,712 $669.37
82607 3,995 3,241 $599.55
84481 2,453 2,026 $514.93
83036 Hemoglobin; glycosylated (A1C) 7,670 5,998 $492.74
36415 Collection of venous blood by venipuncture 15,706 12,785 $378.31
84439 4,116 3,294 $374.53
80050 General health panel 13 13 $316.03
80074 21 19 $292.50
86480 108 96 $253.68
84153 1,568 1,061 $138.25
82728 1,260 1,005 $135.73
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 18 16 $131.44
82746 960 753 $123.73
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 54 45 $116.84
83880 31 21 $115.80
83970 213 187 $109.06
87086 Culture, bacterial; quantitative colony count, urine 1,699 1,588 $104.30
87077 1,552 1,451 $96.24
83540 1,527 1,217 $90.38
83735 635 506 $69.98
86803 34 27 $58.44
86376 17 15 $49.65
81001 5,588 4,492 $48.78
82043 391 370 $42.39
87186 972 836 $42.14
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 10,819 9,509 $34.86
80048 Basic metabolic panel (calcium, ionized) 575 451 $27.03
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 4,549 3,251 $24.18
85652 655 490 $24.05
84550 1,840 1,494 $23.34
84154 101 78 $18.02
87088 1,068 911 $16.53
82977 162 120 $16.16
82248 116 85 $16.13
84100 172 138 $12.53
81005 561 496 $11.55
86140 322 233 $10.59
80069 146 119 $8.51
80305 54 45 $7.48
85027 26 23 $5.14
81015 733 519 $0.00
87500 1,322 888 $0.00
84480 101 87 $0.00
87640 1,522 948 $0.00
84479 244 194 $0.00
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1,469 959 $0.00
84436 402 305 $0.00
82550 20 13 $0.00
86141 69 42 $0.00
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 176 95 $0.00
87641 1,424 891 $0.00
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 253 197 $0.00
87481 1,666 1,023 $0.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,124 1,297 $0.00
85610 499 297 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,817 1,033 $0.00
80076 79 61 $0.00
87653 1,654 1,016 $0.00
81003 128 103 $0.00
83721 24 14 $0.00